aluates Reports

$ 0.0

Automative

Global Acromegaly and Gigantism Treatment Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-3I8140

Global Acromegaly and Gigantism Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Acromegaly and Gigantism Treatment Market Research Report 2025

Code: QYRE-Auto-3I8140

Report

June 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ipsen S A

Novartis

Pfizer Inc

Glide Pharmaceutical

Aegis Therapeutics

Chiasma Inc

Crinetics Pharmaceuticals

Daewoong Pharmaceutical

Peptron

Silence Therapeutics

Strongbridge Biopharma

Amryt Pharma

Foresee Pharmaceuticals

Acromegaly and Gigantism Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Acromegaly and Gigantism Treatment Market

The global market for Acromegaly and Gigantism Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Acromegaly and Gigantism Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly and Gigantism Treatment.

The Acromegaly and Gigantism Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acromegaly and Gigantism Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acromegaly and Gigantism Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acromegaly and Gigantism Treatment Market Report

Report Metric	Details
Report Name	Acromegaly and Gigantism Treatment Market
CAGR	5%
Segment by Type	Somatostatin Analogues Dopamine Agonists
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ipsen, Novartis, Pfizer, Glide Pharmaceutical, Aegis Therapeutics, Chiasma, Crinetics Pharmaceuticals, Daewoong Pharmaceutical, Peptron, Silence Therapeutics, Strongbridge Biopharma, Amryt Pharma, Foresee Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acromegaly and Gigantism Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acromegaly and Gigantism Treatment Market report?

Ans: The main players in the Acromegaly and Gigantism Treatment Market are Ipsen, Novartis, Pfizer, Glide Pharmaceutical, Aegis Therapeutics, Chiasma, Crinetics Pharmaceuticals, Daewoong Pharmaceutical, Peptron, Silence Therapeutics, Strongbridge Biopharma, Amryt Pharma, Foresee Pharmaceuticals

What are the Application segmentation covered in the Acromegaly and Gigantism Treatment Market report?

Ans: The Applications covered in the Acromegaly and Gigantism Treatment Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Acromegaly and Gigantism Treatment Market report?

Ans: The Types covered in the Acromegaly and Gigantism Treatment Market report are Somatostatin Analogues, Dopamine Agonists

Recommended Reports

Endocrine Disorders Treatment

Cancer And Tumor Therapy

General Disease Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acromegaly and Gigantism Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Somatostatin Analogues

1.2.3 Dopamine Agonists

1.3 Market by Application

1.3.1 Global Acromegaly and Gigantism Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acromegaly and Gigantism Treatment Market Perspective (2020-2031)

2.2 Global Acromegaly and Gigantism Treatment Growth Trends by Region

2.2.1 Global Acromegaly and Gigantism Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Acromegaly and Gigantism Treatment Historic Market Size by Region (2020-2025)

2.2.3 Acromegaly and Gigantism Treatment Forecasted Market Size by Region (2026-2031)

2.3 Acromegaly and Gigantism Treatment Market Dynamics

2.3.1 Acromegaly and Gigantism Treatment Industry Trends

2.3.2 Acromegaly and Gigantism Treatment Market Drivers

2.3.3 Acromegaly and Gigantism Treatment Market Challenges

2.3.4 Acromegaly and Gigantism Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acromegaly and Gigantism Treatment Players by Revenue

3.1.1 Global Top Acromegaly and Gigantism Treatment Players by Revenue (2020-2025)

3.1.2 Global Acromegaly and Gigantism Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Acromegaly and Gigantism Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Acromegaly and Gigantism Treatment Revenue

3.4 Global Acromegaly and Gigantism Treatment Market Concentration Ratio

3.4.1 Global Acromegaly and Gigantism Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acromegaly and Gigantism Treatment Revenue in 2024

3.5 Global Key Players of Acromegaly and Gigantism Treatment Head office and Area Served

3.6 Global Key Players of Acromegaly and Gigantism Treatment, Product and Application

3.7 Global Key Players of Acromegaly and Gigantism Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acromegaly and Gigantism Treatment Breakdown Data by Type

4.1 Global Acromegaly and Gigantism Treatment Historic Market Size by Type (2020-2025)

4.2 Global Acromegaly and Gigantism Treatment Forecasted Market Size by Type (2026-2031)

5 Acromegaly and Gigantism Treatment Breakdown Data by Application

5.1 Global Acromegaly and Gigantism Treatment Historic Market Size by Application (2020-2025)

5.2 Global Acromegaly and Gigantism Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Acromegaly and Gigantism Treatment Market Size (2020-2031)

6.2 North America Acromegaly and Gigantism Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Acromegaly and Gigantism Treatment Market Size by Country (2020-2025)

6.4 North America Acromegaly and Gigantism Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acromegaly and Gigantism Treatment Market Size (2020-2031)

7.2 Europe Acromegaly and Gigantism Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Acromegaly and Gigantism Treatment Market Size by Country (2020-2025)

7.4 Europe Acromegaly and Gigantism Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acromegaly and Gigantism Treatment Market Size (2020-2031)

8.2 Asia-Pacific Acromegaly and Gigantism Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Acromegaly and Gigantism Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Acromegaly and Gigantism Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acromegaly and Gigantism Treatment Market Size (2020-2031)

9.2 Latin America Acromegaly and Gigantism Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Acromegaly and Gigantism Treatment Market Size by Country (2020-2025)

9.4 Latin America Acromegaly and Gigantism Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acromegaly and Gigantism Treatment Market Size (2020-2031)

10.2 Middle East & Africa Acromegaly and Gigantism Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Acromegaly and Gigantism Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Acromegaly and Gigantism Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ipsen

11.1.1 Ipsen Company Details

11.1.2 Ipsen Business Overview

11.1.3 Ipsen Acromegaly and Gigantism Treatment Introduction

11.1.4 Ipsen Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.1.5 Ipsen Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Acromegaly and Gigantism Treatment Introduction

11.2.4 Novartis Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Acromegaly and Gigantism Treatment Introduction

11.3.4 Pfizer Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Glide Pharmaceutical

11.4.1 Glide Pharmaceutical Company Details

11.4.2 Glide Pharmaceutical Business Overview

11.4.3 Glide Pharmaceutical Acromegaly and Gigantism Treatment Introduction

11.4.4 Glide Pharmaceutical Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.4.5 Glide Pharmaceutical Recent Development

11.5 Aegis Therapeutics

11.5.1 Aegis Therapeutics Company Details

11.5.2 Aegis Therapeutics Business Overview

11.5.3 Aegis Therapeutics Acromegaly and Gigantism Treatment Introduction

11.5.4 Aegis Therapeutics Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.5.5 Aegis Therapeutics Recent Development

11.6 Chiasma

11.6.1 Chiasma Company Details

11.6.2 Chiasma Business Overview

11.6.3 Chiasma Acromegaly and Gigantism Treatment Introduction

11.6.4 Chiasma Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.6.5 Chiasma Recent Development

11.7 Crinetics Pharmaceuticals

11.7.1 Crinetics Pharmaceuticals Company Details

11.7.2 Crinetics Pharmaceuticals Business Overview

11.7.3 Crinetics Pharmaceuticals Acromegaly and Gigantism Treatment Introduction

11.7.4 Crinetics Pharmaceuticals Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.7.5 Crinetics Pharmaceuticals Recent Development

11.8 Daewoong Pharmaceutical

11.8.1 Daewoong Pharmaceutical Company Details

11.8.2 Daewoong Pharmaceutical Business Overview

11.8.3 Daewoong Pharmaceutical Acromegaly and Gigantism Treatment Introduction

11.8.4 Daewoong Pharmaceutical Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.8.5 Daewoong Pharmaceutical Recent Development

11.9 Peptron

11.9.1 Peptron Company Details

11.9.2 Peptron Business Overview

11.9.3 Peptron Acromegaly and Gigantism Treatment Introduction

11.9.4 Peptron Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.9.5 Peptron Recent Development

11.10 Silence Therapeutics

11.10.1 Silence Therapeutics Company Details

11.10.2 Silence Therapeutics Business Overview

11.10.3 Silence Therapeutics Acromegaly and Gigantism Treatment Introduction

11.10.4 Silence Therapeutics Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.10.5 Silence Therapeutics Recent Development

11.11 Strongbridge Biopharma

11.11.1 Strongbridge Biopharma Company Details

11.11.2 Strongbridge Biopharma Business Overview

11.11.3 Strongbridge Biopharma Acromegaly and Gigantism Treatment Introduction

11.11.4 Strongbridge Biopharma Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.11.5 Strongbridge Biopharma Recent Development

11.12 Amryt Pharma

11.12.1 Amryt Pharma Company Details

11.12.2 Amryt Pharma Business Overview

11.12.3 Amryt Pharma Acromegaly and Gigantism Treatment Introduction

11.12.4 Amryt Pharma Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.12.5 Amryt Pharma Recent Development

11.13 Foresee Pharmaceuticals

11.13.1 Foresee Pharmaceuticals Company Details

11.13.2 Foresee Pharmaceuticals Business Overview

11.13.3 Foresee Pharmaceuticals Acromegaly and Gigantism Treatment Introduction

11.13.4 Foresee Pharmaceuticals Revenue in Acromegaly and Gigantism Treatment Business (2020-2025)

11.13.5 Foresee Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ipsen S A

Novartis

Pfizer Inc

Glide Pharmaceutical

Aegis Therapeutics

Chiasma Inc

Crinetics Pharmaceuticals

Daewoong Pharmaceutical

Peptron

Silence Therapeutics

Strongbridge Biopharma

Amryt Pharma

Foresee Pharmaceuticals

List of Tables

Table 1. Global Acromegaly and Gigantism Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Somatostatin Analogues

Table 3. Key Players of Dopamine Agonists

Table 4. Global Acromegaly and Gigantism Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Acromegaly and Gigantism Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Acromegaly and Gigantism Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Acromegaly and Gigantism Treatment Market Share by Region (2020-2025)

Table 8. Global Acromegaly and Gigantism Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Acromegaly and Gigantism Treatment Market Share by Region (2026-2031)

Table 10. Acromegaly and Gigantism Treatment Market Trends

Table 11. Acromegaly and Gigantism Treatment Market Drivers

Table 12. Acromegaly and Gigantism Treatment Market Challenges

Table 13. Acromegaly and Gigantism Treatment Market Restraints

Table 14. Global Acromegaly and Gigantism Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Acromegaly and Gigantism Treatment Market Share by Players (2020-2025)

Table 16. Global Top Acromegaly and Gigantism Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly and Gigantism Treatment as of 2024)

Table 17. Ranking of Global Top Acromegaly and Gigantism Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Acromegaly and Gigantism Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Acromegaly and Gigantism Treatment, Headquarters and Area Served

Table 20. Global Key Players of Acromegaly and Gigantism Treatment, Product and Application

Table 21. Global Key Players of Acromegaly and Gigantism Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Acromegaly and Gigantism Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Acromegaly and Gigantism Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Acromegaly and Gigantism Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Acromegaly and Gigantism Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Acromegaly and Gigantism Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Acromegaly and Gigantism Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Acromegaly and Gigantism Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Acromegaly and Gigantism Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Acromegaly and Gigantism Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Acromegaly and Gigantism Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Acromegaly and Gigantism Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Acromegaly and Gigantism Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Acromegaly and Gigantism Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Acromegaly and Gigantism Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Acromegaly and Gigantism Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Acromegaly and Gigantism Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Acromegaly and Gigantism Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Acromegaly and Gigantism Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Acromegaly and Gigantism Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Acromegaly and Gigantism Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Acromegaly and Gigantism Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Acromegaly and Gigantism Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Acromegaly and Gigantism Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Ipsen Company Details

Table 47. Ipsen Business Overview

Table 48. Ipsen Acromegaly and Gigantism Treatment Product

Table 49. Ipsen Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 50. Ipsen Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Acromegaly and Gigantism Treatment Product

Table 54. Novartis Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Acromegaly and Gigantism Treatment Product

Table 59. Pfizer Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Glide Pharmaceutical Company Details

Table 62. Glide Pharmaceutical Business Overview

Table 63. Glide Pharmaceutical Acromegaly and Gigantism Treatment Product

Table 64. Glide Pharmaceutical Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 65. Glide Pharmaceutical Recent Development

Table 66. Aegis Therapeutics Company Details

Table 67. Aegis Therapeutics Business Overview

Table 68. Aegis Therapeutics Acromegaly and Gigantism Treatment Product

Table 69. Aegis Therapeutics Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 70. Aegis Therapeutics Recent Development

Table 71. Chiasma Company Details

Table 72. Chiasma Business Overview

Table 73. Chiasma Acromegaly and Gigantism Treatment Product

Table 74. Chiasma Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 75. Chiasma Recent Development

Table 76. Crinetics Pharmaceuticals Company Details

Table 77. Crinetics Pharmaceuticals Business Overview

Table 78. Crinetics Pharmaceuticals Acromegaly and Gigantism Treatment Product

Table 79. Crinetics Pharmaceuticals Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 80. Crinetics Pharmaceuticals Recent Development

Table 81. Daewoong Pharmaceutical Company Details

Table 82. Daewoong Pharmaceutical Business Overview

Table 83. Daewoong Pharmaceutical Acromegaly and Gigantism Treatment Product

Table 84. Daewoong Pharmaceutical Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 85. Daewoong Pharmaceutical Recent Development

Table 86. Peptron Company Details

Table 87. Peptron Business Overview

Table 88. Peptron Acromegaly and Gigantism Treatment Product

Table 89. Peptron Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 90. Peptron Recent Development

Table 91. Silence Therapeutics Company Details

Table 92. Silence Therapeutics Business Overview

Table 93. Silence Therapeutics Acromegaly and Gigantism Treatment Product

Table 94. Silence Therapeutics Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 95. Silence Therapeutics Recent Development

Table 96. Strongbridge Biopharma Company Details

Table 97. Strongbridge Biopharma Business Overview

Table 98. Strongbridge Biopharma Acromegaly and Gigantism Treatment Product

Table 99. Strongbridge Biopharma Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 100. Strongbridge Biopharma Recent Development

Table 101. Amryt Pharma Company Details

Table 102. Amryt Pharma Business Overview

Table 103. Amryt Pharma Acromegaly and Gigantism Treatment Product

Table 104. Amryt Pharma Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 105. Amryt Pharma Recent Development

Table 106. Foresee Pharmaceuticals Company Details

Table 107. Foresee Pharmaceuticals Business Overview

Table 108. Foresee Pharmaceuticals Acromegaly and Gigantism Treatment Product

Table 109. Foresee Pharmaceuticals Revenue in Acromegaly and Gigantism Treatment Business (2020-2025) & (US$ Million)

Table 110. Foresee Pharmaceuticals Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Acromegaly and Gigantism Treatment Picture

Figure 2. Global Acromegaly and Gigantism Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Acromegaly and Gigantism Treatment Market Share by Type: 2024 VS 2031

Figure 4. Somatostatin Analogues Features

Figure 5. Dopamine Agonists Features

Figure 6. Global Acromegaly and Gigantism Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Acromegaly and Gigantism Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Acromegaly and Gigantism Treatment Report Years Considered

Figure 12. Global Acromegaly and Gigantism Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Acromegaly and Gigantism Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Acromegaly and Gigantism Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Acromegaly and Gigantism Treatment Market Share by Players in 2024

Figure 16. Global Top Acromegaly and Gigantism Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly and Gigantism Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Acromegaly and Gigantism Treatment Revenue in 2024

Figure 18. North America Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Acromegaly and Gigantism Treatment Market Share by Country (2020-2031)

Figure 20. United States Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Acromegaly and Gigantism Treatment Market Share by Country (2020-2031)

Figure 24. Germany Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Acromegaly and Gigantism Treatment Market Share by Region (2020-2031)

Figure 32. China Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Acromegaly and Gigantism Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Acromegaly and Gigantism Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Acromegaly and Gigantism Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Ipsen Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 48. Novartis Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 50. Glide Pharmaceutical Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 51. Aegis Therapeutics Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 52. Chiasma Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 53. Crinetics Pharmaceuticals Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 54. Daewoong Pharmaceutical Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 55. Peptron Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 56. Silence Therapeutics Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 57. Strongbridge Biopharma Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 58. Amryt Pharma Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 59. Foresee Pharmaceuticals Revenue Growth Rate in Acromegaly and Gigantism Treatment Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Human Growth Hormone Deficiency Ghd Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hypoparathyroidism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hormonal Infertility Treatment Market Research Report 2022

Global Gravid Treatment Market Research Report 2024

Global Hair Loss Growth Treatment Market Research Report 2025

Fertility Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Treatments for Alpha 1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rare Endocrine Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acromegaly Treatment Market Research Report 2024

Orthodontic Treatment Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acne Treatment Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hypermetropia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tauopathies Treatment Market Research Report 2025

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Glutathione Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hormone Antineoplastic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long Acting Growth Hormone LAGH Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions